Edition:
United States

People: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

21.40USD
9 Dec 2016
Change (% chg)

$0.20 (+0.94%)
Prev Close
$21.20
Open
$21.25
Day's High
$22.15
Day's Low
$20.98
Volume
368,712
Avg. Vol
601,629
52-wk High
$43.63
52-wk Low
$16.40

Sabella, Lauren 

Ms. Lauren M. Sabella is Chief Commercial Officer of Acorda Therapeutics, Inc. Ms. Sabella was the Founder and Principal of Tugboat Consulting Group, an independent consulting practice assisting companies in the commercialization process. Ms. Sabella also served as Corporate Officer and VP of Commercial Development at Altus Pharmaceuticals from May 2006 to September 2008, with responsibility for all aspects of commercialization. Prior to joining Altus, Ms. Sabella was employed by Boehringer Ingelheim Pharmaceuticals for 18 years in positions of increasing responsibility. In her last role, she served as VP of Sales, Eastern Zone, where she led the successful sales launch of Spiriva and ran both Primary Care and Specialty Divisions, including Neurology, Urology and Cardio/Pulmonary. Prior to this role, she had over ten years of marketing experience where she led several brand launches including Mobic, an NSAID which became a $1 billion brand. Ms. Sabella holds a B.B.A. from Hofstra University.

Basic Compensation

Total Annual Compensation, USD 446,885
Restricted Stock Awards, USD 227,505
Long-Term Incentive Plans, USD --
All Other, USD 385,724
Fiscal Year Total, USD 1,060,110

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ron Cohen

4,045,180

David Lawrence

1,204,120

Andrew Blight

1,484,560

Jane Wasman

2,334,280

Burkhard Blank

--

Andrew Hindman

5,167,670
As Of  30 Dec 2014